Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion
NCT06158555
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Critically Ill
Interventions
DRUG:
250 ML NaCl 4.5 MG/ML Injection
Sponsor
King's College Hospital NHS Trust